You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Otsuka is proud to collaborate with leading academic and non-profit research institutions and other private companies on truly paradigm-shifting technologies.
Otsuka is a proud member of the Project to Accelerate New Treatments for Tuberculosis (PAN-TB Collaboration). It is a consortium of philanthropic, non-profit and private sector organisations who aim to create treatment regimens for TB patients that is effective, no matter their drug resistance status.
Otsuka also participates in the EU-Pearl Project. The objective is to revolutionise the way clinical trials are conducted, by making them more efficient (and therefore quicker) and more patient-friendly.
Information current as of 30-12-2020 Reference ONP-COP-2000001